Clinical Evidence of Human Pathogens Implicated in Alzheimer’s Disease Pathology and the Therapeutic Efficacy of Antimicrobials: An Overview

Authors

Celso S G Catumbela
Vijayasree V Giridharan
Tatiana Barichello
Rodrigo Morales

Publication Date

7-26-2023

Journal

Translational Neurodegeneration

Abstract

A wealth of pre-clinical reports and data derived from human subjects and brain autopsies suggest that microbial infections are relevant to Alzheimer's disease (AD). This has inspired the hypothesis that microbial infections increase the risk or even trigger the onset of AD. Multiple models have been developed to explain the increase in pathogenic microbes in AD patients. Although this hypothesis is well accepted in the field, it is not yet clear whether microbial neuroinvasion is a cause of AD or a consequence of the pathological changes experienced by the demented brain. Along the same line, the gut microbiome has also been proposed as a modulator of AD. In this review, we focus on human-based evidence demonstrating the elevated abundance of microbes and microbe-derived molecules in AD hosts as well as their interactions with AD hallmarks. Further, the direct-purpose and potential off-target effects underpinning the efficacy of anti-microbial treatments in AD are also addressed.

Keywords

Humans, Alzheimer Disease, Brain

Comments

PMID: 37496074